Medicanja Values ‘Potential’ Ganja Market At US$1.5b
Medicanja Jamaica Limited, the first local developer of medical marijuana products, says it will be 'open for business' this November when its first six ganja pharmaceuticals are due to hit the local market, through pharmacy channels.
The four-year-old company has invested more than US$3 million in scientific research and product development, according to founder and CEO Dr Henry Lowe, who notes the control over the product cycle, from formulation to commercial-isation, gives Medicanja competitive advantage.
Lowe, a research scientist, asserts that the cannabis industry has the potential to surpass both tourism and remittances in hard currency earnings.
http://jamaica-gleaner.com/article/b...a-market-us15b
Medicanja Jamaica Limited, the first local developer of medical marijuana products, says it will be 'open for business' this November when its first six ganja pharmaceuticals are due to hit the local market, through pharmacy channels.
The four-year-old company has invested more than US$3 million in scientific research and product development, according to founder and CEO Dr Henry Lowe, who notes the control over the product cycle, from formulation to commercial-isation, gives Medicanja competitive advantage.
Lowe, a research scientist, asserts that the cannabis industry has the potential to surpass both tourism and remittances in hard currency earnings.
http://jamaica-gleaner.com/article/b...a-market-us15b
Comment